Psychiatry–Psychology

Articles

• 2018. Keetharuth AD et al. – Integrating Qualitative and Quantitative Data in the Development of Outcome Measures: The Case of the Recovering Quality of Life (ReQoL) Measures in Mental Health Populations
• 2017. François et al. – Creating an index to measure health state of depressed patients in automated healthcare databases: The methodology
• 2017. Soini E et al. – Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland
• 2017. Papadimitropoulou K et al. – Comparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: A systematic review and network meta-analysis
• 2017. Young et al. – Cost-utility evaluation of vortioxetine in patients with major depressive disorder experiencing inadequate response to alternative antidepressants in the United Kingdom
• 2016. Choi SE et al. – Cost-effectiveness of vortioxetine versus venlafaxine (extended release) in the treatment of major depressive disorder in South Korea
• 2016. Rofail D et al. – Assessing the impact on caregivers of patients with schizophrenia: Psychometric validation of the Schizophrenia Caregiver Questionnaire (SCQ)
• 2016. Rofail D et al. – Health-related quality of life in patients with prominent negative symptoms: Results from a multicenter randomized Phase II trial on bitopertin
• 2015. Rofail D et al. – Cross-cultural adaptation of the Schizophrenia Caregiver Questionnaire (SCQ) and the Caregiver Global Impression (CaGl) Scales in 11 languages
• 2013. Higashi K et al. – Medication adherence in schizophrenia: Factors influencing adherence and consequences of non-adherence, a systematic literature review
• 2013. Medic G et al. – Dosing frequency and adherence in chronic psychiatric disease: Systematic review and meta-analysis
• 2012. Annemans L et al. – The impact of treatment with risperidone long-acting injection on the Belgian healthcare system: Results from a budget impact model

Posters & Presentations

• 2016. ISPOR European Congress – Retrospective Database Study Describing Patient Characteristics and Resource Use in Swedish Patients Receiving Second Generation Long Acting Injection Antipsychotics
• 2016. ISPOR European Congress – Cost-Effectiveness Evaluation of Vortioxetine in Major Depressive Episode in the UK Setting
• 2016. ISOQOL Annual Conference – How to Translate “Butterflies in the Stomach” in a Clinical Outcome Assessment Measure? The Example of the Hospital Anxiety and Depression Scale (HADS) into 115 Languages
• 2016. EASD Annual Meeting – Depressive Symptoms in People with Diabetes: Results from the International Diabetes Management Practices Survey
• 2016. ASCP Annual Meeting – Lost in Translation: Translatability of Psychiatric Terms – The Example of the Mini-International Neuropsychiatric Interview (M.I.N.I.)
• 2015. ISPOR European Congress – PRO Self-Assessment and Patient Retention in Major Depression Studies: Efficiency of a Direct-To-Patient Contact Approach
• 2015. ISPOR European Congress – Comparative Efficacy of Ketamine and Other Pharmacological and Somatic Interventions in Adult Patients with Treatment-Resistant Depression: A Network Meta-Analysis
• 2015. ISPOR Annual International Meeting – Cost-Utility of Vortioxetine Versus Venlafaxine XR in the Treatment of Major Depressive Disorder in South Korea
• 2014. ISPOR European Congress – Are “Lively” and “Full of Pep” Similar or Different Concepts? Challenges in Translating these Terms in Seven Languages
• 2014. ISPOR European Congress – The Prevalence of Disease Burden of Treatment-Resistant Depression – A Systematic Review of the Literature
• 2014. ISOQOL Annual Conference – Are “Lively” and “Full of Pep” Similar or Different Concepts? Challenges in Translating These Terms in Seven Languages
• 2014. APA Annual Meeting – Health-related quality of life in people with prominent negative symptoms: results form a multi-center randomised phase II trial on bitopertin
• 2013. ISPOR European Congress – Lost in Translation: Translatability of Psychiatric Terms – The Example of the Mini–International Neuropsychiatric Interview (M.I.N.I.)
• 2013. ISPOR European Congress – Differences in Healthcare Resource Utilization and Expenditures Among Schizophrenic Patients in the United States by Health Insurance Status, 2007-2008
• 2013. ISOQOL Annual Conference – Lost in Translation: Translatability of Psychiatric Terms – The Example of the Mini- International Neuropsychiatric Interview (M.I.N.I.)
• 2012. ISPOR European Congress – Translation of the Alcohol Timeline Followback (TLFB) in 4 Languages
• 2011. ISPOR European Congress – Development and Content Validity of a Patient Reported Outcomes Measure to Assess Symptoms of Major Depressive Disorder (MDD)
• 2009. ISPOR Annual International Meeting – Assessing Anxiety and Depression on an International Level
• 2009. ISPOR Annual International Meeting – Use of the Mini International Neuropsychiatric Interview (M.I.N.I.) – Version 6 – In an International Study
• 2008. ISPOR European Congress – International Investigation into Depression Based on the Structured Interview Guide for the Hamilton Depression Rating Scale (SIGH-D) and the Clinician-Rated Inventory of Depressive Symptomatology (IDS-C)
• 2008. ISPOR European Congress – A Systematic Review on the Epidemiology and Socioeconomic Burden of Bipolar Disorder in Europe
• 2008. ISPOR European Congress – Translation of the Columbia Suicide Severity Rating Scale (C-SSRS) for Use in 33 countries
• 2005. ISPOR European Congress – Development of a Comprehensive Emotional, Somatic and Painful Physical Symptoms Checklist in Depression in Five European Countries
• 2005. ISPOR Annual International Meeting – Quality of Life, Emotional and Physical Symptoms in Depression: A Literature Review of Symptomatology and Patient-Reported Outcome (PRO) Instruments
• 1999. ISPOR Annual International Meeting – Linguistic Validation of the Slice/Life Questionnaire